Zarin Brown

2.6k total citations
38 papers, 2.1k citations indexed

About

Zarin Brown is a scholar working on Immunology, Oncology and Physiology. According to data from OpenAlex, Zarin Brown has authored 38 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Oncology and 8 papers in Physiology. Recurrent topics in Zarin Brown's work include Chemokine receptors and signaling (7 papers), Renal Diseases and Glomerulopathies (7 papers) and Adenosine and Purinergic Signaling (5 papers). Zarin Brown is often cited by papers focused on Chemokine receptors and signaling (7 papers), Renal Diseases and Glomerulopathies (7 papers) and Adenosine and Purinergic Signaling (5 papers). Zarin Brown collaborates with scholars based in United Kingdom, United States and Switzerland. Zarin Brown's co-authors include Ellen Herlaar, John Westwick, Guy H. Neild, Rachel L. Robson, Catherine M. Hawrylowicz, Robert M. Strieter, David F. Richards, Zoë Urry, Emmanuel Xystrakis and Steven L. Kunkel and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Zarin Brown

38 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zarin Brown United Kingdom 20 813 482 363 325 301 38 2.1k
Maryvonne Daveau France 28 562 0.7× 784 1.6× 303 0.8× 243 0.7× 211 0.7× 86 2.6k
T Kishimoto Japan 20 793 1.0× 683 1.4× 728 2.0× 265 0.8× 177 0.6× 35 2.7k
Robin Kunkel United States 14 747 0.9× 907 1.9× 148 0.4× 325 1.0× 131 0.4× 16 2.4k
Jun‐Ki Min South Korea 35 1.1k 1.3× 848 1.8× 352 1.0× 156 0.5× 207 0.7× 80 2.6k
Angelo Guglielmotti Italy 29 818 1.0× 573 1.2× 566 1.6× 167 0.5× 84 0.3× 59 2.5k
J. R. Kalden Germany 31 1.6k 2.0× 1.0k 2.1× 427 1.2× 233 0.7× 294 1.0× 99 3.5k
Xuebin Qin United States 33 1.4k 1.7× 1.1k 2.3× 225 0.6× 344 1.1× 207 0.7× 93 3.6k
Duncan A. Gordon United Kingdom 22 1.0k 1.2× 371 0.8× 229 0.6× 140 0.4× 349 1.2× 59 2.6k
Lloyd Mayer United States 15 1.1k 1.3× 1.0k 2.1× 464 1.3× 558 1.7× 209 0.7× 27 3.7k
Jeng‐Hsien Yen Taiwan 29 1.3k 1.7× 556 1.2× 368 1.0× 125 0.4× 233 0.8× 132 2.7k

Countries citing papers authored by Zarin Brown

Since Specialization
Citations

This map shows the geographic impact of Zarin Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zarin Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zarin Brown more than expected).

Fields of papers citing papers by Zarin Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zarin Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zarin Brown. The network helps show where Zarin Brown may publish in the future.

Co-authorship network of co-authors of Zarin Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Zarin Brown. A scholar is included among the top collaborators of Zarin Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zarin Brown. Zarin Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Zarin, et al.. (2014). Characterization QAW039 and QAV680, two novel, potent and selective CRTh2 antagonists. European Respiratory Journal. 44(Suppl 58). P4072–P4072. 5 indexed citations
2.
Brown, Zarin, Steven J. Charlton, Brian J. Cox, et al.. (2014). The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 24(15). 3285–3290. 15 indexed citations
3.
Porter, David W., Zarin Brown, Steven J. Charlton, et al.. (2013). The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 24(1). 72–76. 17 indexed citations
4.
Bhalay, Gurdip, Mohammed Shahid Akhlaq, David Beer, et al.. (2011). Design and synthesis of a library of chemokine antagonists. Bioorganic & Medicinal Chemistry Letters. 21(21). 6249–6252. 4 indexed citations
5.
Urry, Zoë, et al.. (2010). 1a,25-dihydroxyvitamin D3 differentially promotes Foxp3 and IL-10 expression by human CD4+T cells. Immunology. 131. 184–184. 2 indexed citations
6.
Beattie, David T., Zarin Brown, Steven J. Charlton, et al.. (2009). Synthesis and evaluation of two series of 4′-aza-carbocyclic nucleosides as adenosine A2A receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(3). 1219–1224. 9 indexed citations
7.
8.
Lloyd, Clare M. & Zarin Brown. (2006). Chemokine Receptors. PubMed. 5(3). 159–166. 8 indexed citations
9.
Cronshaw, Darran G., Charles Owen, Zarin Brown, & Stephen G. Ward. (2004). Activation of Phosphoinositide 3-Kinases by the CCR4 Ligand Macrophage-Derived Chemokine Is a Dispensable Signal for T Lymphocyte Chemotaxis. The Journal of Immunology. 172(12). 7761–7770. 45 indexed citations
10.
Stevenson, Christopher S., K. Coote, Ruth Webster, et al.. (2004). Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. American Journal of Physiology-Lung Cellular and Molecular Physiology. 288(3). L514–L522. 78 indexed citations
11.
Tang, Sydney, Neil Sheerin, Wuding Zhou, Zarin Brown, & Steven H. Sacks. (1999). Apical Proteins Stimulate Complement Synthesis by Cultured Human Proximal Tubular Epithelial Cells. Journal of the American Society of Nephrology. 10(1). 69–76. 87 indexed citations
12.
Herlaar, Ellen & Zarin Brown. (1999). p38 MAPK signalling cascades in inflammatory disease. Molecular Medicine Today. 5(10). 439–447. 490 indexed citations
13.
Robson, Rachel L., John Westwick, & Zarin Brown. (1995). Interleukin-1-induced IL-8 and IL-6 gene expression and production in human mesangial cells is differentially regulated by cAMP. Kidney International. 48(6). 1767–1777. 35 indexed citations
14.
Brown, Zarin, Robert M. Strieter, Guy H. Neild, et al.. (1992). IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells. Kidney International. 42(1). 95–101. 76 indexed citations
15.
Brown, Zarin, Lynette D. Fairbanks, Robert M. Strieter, et al.. (1991). Human Mesangial Cell-Derived Interleukin 8 and Interleukin 6: Modulation by an Interleukin 1 Receptor Antagonist. Advances in experimental medicine and biology. 305. 137–145. 3 indexed citations
16.
Neild, Guy H. & Zarin Brown. (1991). Endothelium and Glomerular Growth. American Journal of Kidney Diseases. 17(6). 670–672. 3 indexed citations
17.
Brown, Zarin, Robert M. Strieter, Stephen W. Chensue, et al.. (1991). Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney International. 40(1). 86–90. 77 indexed citations
18.
19.
Lanham, J, et al.. (1986). Prostacyclin deficiency in a young woman with recurrent thrombosis.. BMJ. 292(6518). 435–436. 3 indexed citations
20.
Imberti, Luisa, et al.. (1983). EFFECT OF CYCLOSPORINE ON PROSTACYCLIN SYNTHESIS BY VASCULAR TISSUE IN RABBITS. UCL Discovery (University College London). 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryvonne Daveau Breakdown of academic impact, for papers by T Kishimoto Breakdown of academic impact, for papers by Robin Kunkel Breakdown of academic impact, for papers by Jun‐Ki Min Breakdown of academic impact, for papers by Angelo Guglielmotti Breakdown of academic impact, for papers by J. R. Kalden Breakdown of academic impact, for papers by Xuebin Qin Breakdown of academic impact, for papers by Duncan A. Gordon Breakdown of academic impact, for papers by Lloyd Mayer Breakdown of academic impact, for papers by Jeng‐Hsien Yen
Rankless by CCL
2026